Ségolène de Marsac Appointed CEO of Opella France
Ségolène de Marsac has been appointed Chief Executive Officer of Opella France, effective immediately. She succeeds Paul-François Cossa.
Opella announced the appointment of Ségolène de Marsac as Chief Executive Officer of Opella France, effective immediately. De Marsac succeeds Paul-François Cossa, who was instrumental in establishing and developing Opella France since 2022.
De Marsac brings extensive experience and a strategic vision to one of Opella's key markets. She joined Opella in 2018 as Marketing Director France, later heading the global winter ailments category and serving as General Manager for Enterogermina, a global leader in probiotics. She also led Opella's global sustainability teams, contributing to B Corp certification across numerous markets. Her prior experience includes leadership roles at Danone and Thaï Union.
Opella operates as a global player in everyday health, focusing on over-the-counter (OTC) medicines and vitamins, minerals, and supplements (VMS). France represents Opella's second-largest global market. De Marsac aims to strengthen Opella's presence in France and promote innovations that empower consumers to manage their health.
The company's mission is to make everyday health accessible and simple. France plays a crucial role in this strategy, supported by 1,700 employees at the headquarters, the subsidiary, and the manufacturing sites in Compiègne and Lisieux, where the product Doliprane is produced.